Streetbeat News

Products Services

G

Genpact (NYSE:G) is expanding its partnership with o9 Solutions to deliver a planning-as-a-service offering that leverages generative AI. The service combines Genpact's expertise in digital innovation, process, supply chain transformation, and experience running digital operations with o9's technologies in generative AI, machine learning, and other digital intelligence capabilities. The service aims to help companies navigate ongoing supply chain disruptions.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 12:12 pm

VTGN

Vistagen (NASDAQ:VTGN) has reported new preclinical data supporting the potential antidepressant activity of its Itruvone nasal spray. The study showed that the spray binds to receptors of peripheral chemosensory neurons in the nasal cavity, limiting transport of molecules to the circulatory system and minimizing potential systemic exposure. The company believes this could change the treatment paradigm for depression disorders. Vistagen recently reported that Itruvone is now staged for potential Phase 2B clinical development in the U.S. as a stand-alone treatment for major depressive disorder (MDD).

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:08 pm

CUEN

CUENW

OLB

Cuentas, Inc. (NASDAQ:CUEN) (NASDAQ:CUENW) announced that OLB Group (NASDAQ:OLB) has acquired the remaining controlling interest of Cuentas SDI LLC. Cuentas will retain its 19.99% share in Cuentas SDI and will be providing additional services to the network, including the Company's new Cuentas Mobile Wireless Service. The companies plan to offer an increasing array of next-generation location-based physical and digital services to accelerate growth. The partnership aims to increase offerings to the underserved markets and expand across the nation.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:07 pm

ARQT

CVS

Arcutis Biotherapeutics announced that its product Zoryve (Roflumilast) Cream 0.3% for plaque psoriasis is now covered as a preferred tier product on CVS Caremark's largest national commercial formularies.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:05 pm

PDSB

PDS Biotechnology Corporation (NASDAQ:PDSB) announced that an abstract on interim data from a clinical trial evaluating the combination of PDS0301, an IL-12-based immunocytokine, with the chemotherapy medication docetaxel has been accepted for oral presentation at the 11th Annual Meeting of the International Cytokine & Interferon Society (Cytokines 2023). The trial is investigating the safety, immune responses and clinical activity of PDS0301 and docetaxel in metastatic castration-sensitive and castration-resistant prostate cancer patients.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:05 pm

ENVB

Enveric Biosciences has reported results from animal studies showing oral bioavailability and a well-tolerated side effect profile for EB-373. The results could potentially lead to further development and testing of the drug.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:04 pm

ICCM

IceCure Medical has expanded the distribution of its ProSense system into Portugal through an agreement with Medicinália Cormédica. The ProSense system is used for the treatment of benign and malignant tumors.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:03 pm

MDGL

Madrigal Pharmaceuticals has completed the rolling submission of its New Drug Application (NDA) to the FDA for Resmetirom, a treatment for NASH with liver fibrosis. The company has requested a priority review of the application.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:03 pm

JANX

Janux Therapeutics has announced interim clinical data from its Phase 1a dose escalation for PSMA-TRACTr JANX007 and an update on pipeline programs. The preliminary data showed encouraging safety results with no dose-limiting toxicities. The company will host a virtual investor event today at 4:00 PM Eastern Time.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:02 pm

BTCUSD

ETHUSD

Binance has integrated the Bitcoin Lightning Network on its platform for BTC withdrawals and deposits. This comes three months after Binance temporarily halted BTC withdrawals due to network congestion. The Lightning Network is a development aimed at enhancing the speed and cost efficiency of Bitcoin transactions. Coinbase CEO Brian Armstrong had previously indicated his intention to integrate the Bitcoin layer 2 network on Coinbase.

Portfolio Pulse from Mehab Qureshi

July 17, 2023 | 11:52 am